| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |